Recent progress in small-molecule targeted therapies for melanoma treatment
Bioorganic & Medicinal Chemistry · 2026-08 · 139 · 118699
DOI: 10.1016/j.bmc.2026.118699 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioorganic & Medicinal Chemistry, 2026-08. Verfasst von Xinrui Yuan und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jiangsu University, 301 Xuefu Road, Zhenjiang 212000, PR China. Hauptthemen laut MEDLINE: Melanoma, Small Molecule Libraries, Antineoplastic Agents, Molecular Targeted Therapy. Die Arbeit nennt 159 Literaturangaben. Gefördert von: Senior Talent Foundation of Jiangsu University.
Abstract (Originalsprache)
Melanoma is an aggressive form of skin cancer that originates from melanocytes and has a high risk of metastasis to distant organs. The identification of specific mutations and the subsequent development of targeted therapies have revolutionized the landscape of small-molecule drugs for melanoma. However, the acquired resistance and low response in a subset of melanoma patients promote continued research and clinical study for novel small-molecule targeted therapies. In recent years, several innovative targeted therapies and small-molecule strategies have been explored, which provide more options for melanoma patients. This review will summarize recent advances in targeted therapy for melanoma, with a focus on emerging small-molecule strategies and an update on their clinical progress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Jiangsu University, 301 Xuefu Road, Zhenjiang 212000, PR China.
- Center of Drug Discovery, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, PR China.
- School of Pharmacy, Jiangsu University, 301 Xuefu Road, Zhenjiang 212000, PR China. Electronic address: leihu@ujs.edu.cn.
- Center of Drug Discovery, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, PR China. Electronic address: zhanghb80@cpu.edu.cn.
Förderung
- Senior Talent Foundation of Jiangsu University
Zitieren
APA
Yuan, X., Xu, H., Pei, Y., Guan, D., Hu, L., & Zhang, H. (2026). Recent progress in small-molecule targeted therapies for melanoma treatment. Bioorganic & Medicinal Chemistry, 139, 118699. https://doi.org/10.1016/j.bmc.2026.118699
Vancouver
Yuan X, Xu H, Pei Y, Guan D, Hu L, Zhang H. Recent progress in small-molecule targeted therapies for melanoma treatment. Bioorganic & Medicinal Chemistry. 2026;139:118699. doi:10.1016/j.bmc.2026.118699
BibTeX
@article{Yuan2026,
author = {Yuan, Xinrui and Xu, Hongyan and Pei, Yifeng and Guan, Dezhong and Hu, Lei and Zhang, Huibin},
title = {Recent progress in small-molecule targeted therapies for melanoma treatment},
journal = {Bioorganic & Medicinal Chemistry},
year = {2026},
volume = {139},
pages = {118699},
doi = {10.1016/j.bmc.2026.118699}
}
EUVIMED